Literature DB >> 17366100

Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.

Helén Marklund-Bau1, Ulla Edéll-Gustafsson, Anders Spångberg.   

Abstract

OBJECTIVES: Firstly, to describe self-reported urinary symptoms and bothersomeness, including disease-specific quality of life (QOL), in patients with symptomatic benign prostatic obstruction (BPO) before and 6 months after intervention. Secondly, to identify factors which predict disease-specific QOL. Thirdly, to develop and test the reliability of an instrument to evaluate incontinence, the Linköping Incontinence Questionnaire (LIQ). Finally, to translate and test the reliability of Swedish versions of the International Prostate Symptom Score, including the bother question, the American Urological Association Symptom Problem Index (SPI) and the Benign Prostatic Hyperplasia Impact Index.
MATERIAL AND METHODS: Disease-specific QOL was studied in 572/720 consecutively treated patients using structured questionnaires. The reliability of the instruments was tested in 122 patients with lower urinary tract symptoms (LUTS) or BPO.
RESULTS: The frequency and weak stream items of the SPI were among those that best explained the patients' disease-specific QOL both before and after intervention. Before and after intervention the prevalence of urinary incontinence, assessed using the LIQ instrument, was 46% and 16%, respectively. Symptoms and disease-specific QOL improved most in the surgery group, intermediately in the transurethral incision of the prostate/transurethral microwave thermotherapy group and least in the drug therapy group.
CONCLUSIONS: The frequency and weak stream items of the SPI were the factors that best explained disease-specific QOL. The prevalence of incontinence before and after intervention was higher than that previously reported.

Entities:  

Mesh:

Year:  2007        PMID: 17366100     DOI: 10.1080/00365590601068926

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care.

Authors:  Edmond P H Choi; Cindy L K Lam; Weng-Yee Chin
Journal:  Qual Life Res       Date:  2014-06-12       Impact factor: 4.147

2.  Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.

Authors:  Petros Sountoulides; Marleen M van Dijk; Hessel Wijkstra; Jean J M C H de la Rosette; Martin Christian Michel
Journal:  World J Urol       Date:  2009-10-09       Impact factor: 4.226

Review 3.  The floppy iris syndrome - what urologists and ophthalmologists need to know.

Authors:  Faruquz Zaman; Christian Bach; Islam Junaid; Athanasios G Papatsoris; Jhumur Pati; Junaid Masood; Noor Buchholz
Journal:  Curr Urol       Date:  2012-04-30

4.  Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.

Authors:  Tiago Santos Prata; Pat-Michael Palmiero; Allison Angelilli; Zaher Sbeity; Carlos Gustavo V De Moraes; Jeffrey M Liebmann; Robert Ritch
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

5.  Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies.

Authors:  Mallik Angalakuditi; Rita F Seifert; Risa P Hayes; Michael P O'Leary; Lars Viktrup
Journal:  Health Qual Life Outcomes       Date:  2010-11-12       Impact factor: 3.186

6.  Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin.

Authors:  Bob Djavan; Seyed Saeid Dianat; Amir Kazzazi
Journal:  Patient Relat Outcome Meas       Date:  2011-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.